News
BNGO
--
0.00%
--
Bionano Genomics to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 13, 2021
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, May 13, 2021 at 4:30 p.m. Eastern Time to report financial results for the first quarter end...
GlobeNewswire · 2d ago
Bionano Genomics secures new patent in U.S.
The USPTO will issue Bionano Genomics ([[BNGO]] -4.4%) U.S. Patent No. 10,995,364 today. The patent, titled “METHODS AND DEVICES FOR SINGLE-MOLECULE WHOLE GENOME ANALYSIS” covers methods for labeling DNA molecules with
Seekingalpha · 5d ago
Bionano Genomics Announces Issuance of US Patent for Targeted Labeling Strategy to Complement Whole Genome Analysis Using Optical Genome Mapping
GlobeNewswire · 5d ago
BRIEF-Bionano Genomics Says Georgia Esoteric And Molecular Laboratory Now Offers Diagnostic Service For Genetic Disorders
reuters.com · 6d ago
Georgia Esoteric and Molecular Laboratory at Augusta University Now Offers Diagnostic Service for Constitutional Genetic Disorders based on Optical Genome Mapping with Bionano’s Saphyr System
SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that the Georgia Esoteric and Molecular (GEM) Laboratory at the Medical College of Georgia (MCG) at Augusta University is now offering diagnostic services fo...
GlobeNewswire · 6d ago
Bionano Genomics, Inc. (BNGO) Dips More Than Broader Markets: What You Should Know
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session.
Zacks · 04/28 21:50
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc.
Benzinga · 04/27 16:03
58 Biggest Movers From Yesterday
Gainers
Benzinga · 04/27 09:03
What's Going On With Bionano Genomics Stock Today?
BioNano Genomics Inc (NASDAQ: BNGO) shares are trading higher by 19.5% at $7.36 Monday on continued strength following last week’s publication of DNA replication data, a fundamental process of cell growth implicated in cancer that was previously hard to st...
Benzinga · 04/26 18:49
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 04/26 16:52
Archford Capital Strategies, LLC Buys Sprout Social Inc, iShares MBS ETF, Vanguard ...
GuruFocus News · 04/26 11:38
Thinking about buying stock in Naked Brand, Sundial Growers, Advanced Micro Devices, BioNano Genomics, or Palantir Technologies?
NEW YORK, April 23, 2021 /PRNewswire via COMTEX/ -- NEW YORK, April 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAKD,...
PR Newswire - PRF · 04/23 15:33
Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025
Apr 23, 2021 (Financial News Media via COMTEX) -- Palm Beach, FL - April 23, 2021 - Sleep is an essential need of all species... including homo sapiens,...
Financial News Media · 04/23 12:46
Bionano Genomics Publishes New Study On DNA Replication; Shares Gain In Pre-Market
TipRanks.com · 04/23 11:44
DJ Bionano Genomics Shares Rise 10% on Positive Study Results for Saphyr System
Dow Jones · 04/22 14:10
Thinking about buying stock in Novan, Qualtrics International, BioNano Genomics, XL Fleet, or Atossa Therapeutics?
NEW YORK, April 22, 2021 /PRNewswire via COMTEX/ -- NEW YORK, April 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOVN,...
PR Newswire - PRF · 04/22 13:31
Bionano Genomics shares surge 9% on Saphyr system DNA replication data
Bionano Genomics' (BNGO) Saphyr system was able to determine the timing, speed and origin of DNA replication in human cells at a much higher rate than currently available methods.The study
Seekingalpha · 04/22 12:45
Bionano Genomics Announces Publication of New Approach to Study DNA Replication Using Optical Genome Mapping With Saphyr, Potentially Supporting Development of Cancer Drugs Targeting Replication Pathways
Publication on novel Saphyr-based method to analyze DNA replication in human genomes could enable new level of cancer research and drug discovery, exemplifies the importance of optical genome mapping in large research marketSAN DIEGO, April 22, 2021 (GLOBE...
GlobeNewswire · 04/22 12:12
2 Biopharma Stocks That Look Ready For A Bullish Reversal
Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wedn
Benzinga · 04/21 19:27
BRIEF-Bionano Genomics Reports Sites Within UK's NHS Have Adopted Its Saphyr System
reuters.com · 04/21 12:15
Webull provides a variety of real-time BNGO stock news. You can receive the latest news about Bionano Genomics through multiple platforms. This information may help you make smarter investment decisions.
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response. The Company’s subsidiary, Lineagen, Inc., provides molecular diagnostics services for individuals.